Charlotte Oehman

Innovenn, established in 2014, helps develop patient-centered health innovations to improve health through enabling data driven Precision Medicine. With years of experience in drug and device development utilizing a structured risk-based lifecycle process, the Innovenn team will help manage successful product development projects enabling regulatory approvals, product adoption and market success for patient-centric health innovations. We offer a powerful combination of skills and capabilities to leverage process, scientific rigor, and data to design and launch patient-centered health innovations that enable Precision Medicine, target unmet needs, and improve patient health.